At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,013 enrolled
Drug / intervention
lab draws and imagingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
In Brief
A Phase 4 clinical trial evaluating lab draws and imaging for Psoriasis and Psoriatic Arthritis. Completed, enrolled 1,013 participants across 45 sites in 7 countries.
Detailed Summary
This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a dermatologist at visit 1 and by a rheumatologist at visit 2. A subset of subjects will then go on to visit 3 for imaging procedures (x-ray, MRI, and ultrasound).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis, Psoriatic Arthritis
CountriesBelgium, Canada, Denmark, France, Germany, Hungary, United States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2010
Enrollment StartAug 2010
Primary CompletionJul 2011
TodayJul 2026
First PostedJun 22, 2010
Enrollment StartAug 1, 2010
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.0 years ago
Interventions
lab draws and imagingprocedure
1 set of lab draws, imaging consists of radiographic imaging or X-ray, ultrasound and MRI